Accelerate Breakthroughs in Cancer Treatment: Support Dr. Carl June's Pioneering Research
Empower Dr. Carl June's ongoing mission to revolutionize cancer treatment through advanced T cell-based therapies. For over two decades, the June Laboratory has been at the forefront of innovative cancer gene therapy, making significant strides in lymphocyte costimulation and CAR T cell technology. From pioneering the clinical use of lentiviruses to modify T cells in combating HIV and advanced leukemia, to achieving 'Breakthrough Therapy' status from the FDA for treating acute leukemia and lymphoma, Dr. June's work offers hope to millions battling these diseases. By contributing to this groundbreaking research, you become part of a transformative journey, helping to bring these life-saving therapies from the laboratory to widespread clinical use.
Dr. June, Carl
Transforming Cancer Treatment
Dr. June's CAR T cell therapies have shown remarkable results in treating acute leukemia in children and adults, and lymphoma in adults. Supporting this research contributes to developing more effective, targeted treatments for these devastating diseases.
Advancing Gene Therapy
The technology developed in the June Laboratory has been pivotal in progressing cancer gene therapy. This approach offers a new paradigm in treating cancers that have been resistant to traditional therapies.
Wider Application and Accessibility
With ongoing development and anticipated FDA approval, the therapies pioneered by Dr. June are set to become more widely available, potentially benefiting a vast number of patients globally.
Your support is not just a donation; it's an investment in a future where cancer can be effectively combated through advanced gene therapy. Join us in backing Dr. Carl June’s transformative work, paving the way for new horizons in cancer treatment and giving hope to millions around the world.